Intelligence · Patents
Patents expiring in 2030
Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.
- Patents
- 905
Quick answer
905 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7777027
Purified beta glucan composition
granted -
US 7776908
Wortmannin analogs and methods of using same
granted -
US 7776521
Coronavirus isolated from humans
granted -
US 7776827
Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome
granted -
US 7776883
Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)
granted -
US 7776879
Quinuclidine carbamate derivatives and their use as M3 antagonists
granted -
US 7776816
Preserving hypoxic tissue
granted -
US 7776593
Hes6 as a marker of pancreatic endocrine cells
granted -
US 7776548
Endocytotic pathway delivery vehicle for targeting drugs and antibodies to prostate and other tissues
granted -
US 7776564
Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use
granted -
US 7776887
Processes and intermediates
granted -
US 7776847
Benzisothiazoles useful for treating or preventing HCV infection
granted -
US 7776320
Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
granted -
US 7777077
Dual-acting antihypertensive agents
granted -
US 7781577
Inhibitors of sodium glucose co-transporter 2 and methods of their use
granted -
US 7780963
Anti-ADDL antibodies and uses thereof
granted -
US 7780966
Artificial invaplex
granted -
US 7781397
Human plasma hyaluronidase
granted -
US 7781404
IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof
granted -
US 7781445
Synthesis of indenoisoquinoliniums and methods of use
granted -
US 7781449
Trospium chloride treatment method
granted -
US 7781565
Compositions and methods related to profiling a plurality of cells based on peptide binding
granted -
US 7781448
Once daily dosage forms of trospium
granted -
US 7781478
Methods for treating hepatitis C
granted -
US 7781175
Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid
granted -
US 7781413
SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
granted -
US 7781584
Dipeptidyl peptidase inhibitors
granted -
US 7786083
Metastin derivatives and use thereof
granted -
US 7788045
Systems and method for homeostatic blood states
granted -
US 7786308
Muscarinic modulators
granted -
US 7786285
Recombinant vaccine against botulinum neurotoxin
granted -
US 7786282
Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
granted -
US 7786221
Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules
granted -
US 7786213
Biomacromolecule polymer conjugates
granted -
US 7786130
Pyridones useful as inhibitors of kinases
granted -
US 7786141
Dihydrospiroindene modulators of muscarinic receptors
granted -
US 7786136
Indazole-carboxamide compounds
granted -
US 7786133
Chemically modified small molecules
granted -
US 7786100
Composition and method of treating hearing loss
granted -
US 7786091
Compositions and methods for ameliorating myosin VIIa defects
granted -
US 7786080
Mutein of a bone morphogenetic protein and use thereof
granted -
US 7784616
Dispenser for progestin used for acute maintenance treatment of DUB
granted -
US 7785886
Methods and reagents for modulating cholesterol levels
granted -
US 7785806
Method for determining the immunogenicity of an antigen
granted -
US 7785597
VMP-like sequences of pathogenic Borrelia
granted -
US 7786290
Double-stranded ribonucleic acid with increased effectiveness in an organism
granted -
US 7785565
Metal chelators and methods of their use
granted -
US 7786316
Metalloprotein inhibitors
granted
Frequently asked questions
How many pharma patents expire in 2030?
905 published patents in our USPTO index have expiration dates falling in calendar year 2030.